{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:38:03Z","timestamp":1785274683442,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>BiCoVac is a population-based Danish cohort aiming to examine whether Coronavirus disease 2019 (COVID-19) vaccines are associated with non-specific symptoms beyond the specific protection of COVID-19. Data were collected by four questionnaire surveys between May 2021 and July 2022 and the questionnaire distribution was aligned with the Danish COVID-19 vaccination program. All surveys collected self-reported information on symptoms (e.g., headache, nausea, and fatigue). The baseline survey additionally gathered information on lifestyle and health. Survey data were combined with data from the Danish registers including information on COVID-19 vaccination and COVID-19 test results. A total of 911,613 (25% of all Danish citizens aged 16 to 65) were randomly sampled for the cohort and 252,401 initiated the baseline questionnaire. Of these, 59% (<jats:italic>n<\/jats:italic>\u2009=\u2009149,070) participated in the 1st follow-up, 43% (<jats:italic>n<\/jats:italic>\u2009=\u2009107,655) in the 2nd follow-up, and 25% (<jats:italic>n<\/jats:italic>\u2009=\u200963,737) in the 3rd follow-up. Women and individuals above 40 years of age were more likely to participate. Among vaccinated respondents, 25\u201338% reported moderate to severe immediate symptoms following COVID-19 vaccination, varying by vaccine doses. Females, younger individuals, and those with prior COVID-19 reported more immediate symptoms. Results of potential non-specific symptoms following COVID-19 vaccination did not reveal higher risk of involuntary movements among vaccinated individuals compared to unvaccinated individuals. Currently (December 2024), we are further investigating the effects of COVID-19 vaccines on other non-specific symptoms and exploring whether specific characteristics render some individuals more susceptible to report non-specific symptoms. In addition, long-term symptoms following COVID-19 are being investigated.<\/jats:p>","DOI":"10.1007\/s10654-025-01204-1","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:29:04Z","timestamp":1738920544000},"page":"225-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cohort profile: The BiCoVac cohort - a nationwide Danish cohort to assess short and long-term symptoms following COVID-19 vaccination"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5120-5589","authenticated-orcid":false,"given":"Christina Bisgaard","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3120-8790","authenticated-orcid":false,"given":"Kristoffer Torp","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3622-9739","authenticated-orcid":false,"given":"Casper Mailund","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0877-556X","authenticated-orcid":false,"given":"Stefan Nygaard","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0841-8255","authenticated-orcid":false,"given":"Henrik","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7426-0353","authenticated-orcid":false,"given":"Charlotte Ulrikka","family":"Rask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2921-4099","authenticated-orcid":false,"given":"Per","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7437-7052","authenticated-orcid":false,"given":"Thomas Meinertz","family":"Dantoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-2830","authenticated-orcid":false,"given":"Torben","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0287-3687","authenticated-orcid":false,"given":"Bodil Hammer","family":"Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4541-3901","authenticated-orcid":false,"given":"Sanne M\u00f8ller","family":"Thysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-0975","authenticated-orcid":false,"given":"Dorte","family":"Rytter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"1204_CR1","unstructured":"Mathieu E, Ritchie H, Rod\u00e9s-Guirao L, Appel C, Giattino C, Hasell J et al. Coronavirus Pandemic (COVID-19). 2024. https:\/\/ourworldindata.org\/coronavirus. Accessed 8 Jan 2024."},{"key":"1204_CR2","unstructured":"Sundhedsstyrelsen. Vaccinationskalender 1J. 2021. 2021. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2021\/Corona\/Vaccination\/Kalender\/Specificeret-vaccinationskalender-01072021.ashx. Accessed 22 Jan 2024]."},{"key":"1204_CR3","unstructured":"Sundhedsstyrelsen. Denmark continues its vaccine rollout without the COVID-19 vaccine from AstraZeneca. 2021. https:\/\/www.sst.dk\/da\/Nyheder\/2021\/Danmark-fortsaetter-vaccineudrulning-uden-AstraZeneca-vaccinen. Accessed 8 Jan 2024."},{"key":"1204_CR4","unstructured":"Indenrigs og Sundhedsministeriet. Tilvalgsordningen for Covid-19 vacciner tr\u00e6der i kraft i denne uge. 2021. https:\/\/sum.dk\/nyheder\/2021\/maj\/tilvalgsordningen-for-covid-19-vacciner-traeder-i-kraft-i-denne-uge. Accessed 8 Jan 2024."},{"key":"1204_CR5","unstructured":"Sundhedsstyrelsen. Anbefalinger vedr\u00f8rende revaccination mod COVID-19 af personer med sv\u00e6rt nedsat immunforsvar. 2021. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2021\/Corona\/Retningslinjer\/Tidlig-revaccination-af-personer-med-nedsat-immunforsvar-300821_4.ashx?la=da&hash=4B39D17E1C5698976C867B869AE5F7615AA7BC14. Accessed 8 Jan 2024."},{"key":"1204_CR6","unstructured":"Sundhedsstyrelsen. Anbefalinger vedr. 4. stik covid-19 vaccine til personer med sv\u00e6rt nedsat immunforsvar. 2022. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2022\/Corona\/Retningslinjer\/Anbefalinger-vedr_-4_-stik-covid-19-vaccine-til-personer-med-svaert-nedsat-immunforsvar.ashx. Accessed 8 Jan 2024."},{"key":"1204_CR7","unstructured":"Sundhedsstyrelsen. Vaccinations program mod covid-19 i efter\u00e5r\/vinter. 2022\/23. 2022. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2022\/Corona\/Vaccination\/Efteraar\/Anbefalinger-vaccinationsprogram-efteraar-2022.ashx. Accessed 7 Jan 2025."},{"key":"1204_CR8","unstructured":"Sundhedsstyrelsen. Planl\u00e6gningsgrundlag for vaccinations-program mod covid-19 s\u00e6son 2023\/24. 2023. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2023\/Vaccination\/2023-2024\/Planlaegningsgrundlag-for-vaccinationsprogram-mod-covid-19-saeson-202324.ashx. Accessed 8 Jan 2024."},{"key":"1204_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.puhe.2021.02.025","volume":"194","author":"G Troiano","year":"2021","unstructured":"Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245\u201351. https:\/\/doi.org\/10.1016\/j.puhe.2021.02.025.","journal-title":"Public Health"},{"issue":"9","key":"1204_CR10","doi-asserted-by":"publisher","first-page":"e1003768","DOI":"10.1371\/journal.pmed.1003768","volume":"18","author":"LW Krogsgaard","year":"2021","unstructured":"Krogsgaard LW, Petersen I, Plana-Ripoll O, Bech BH, L\u00fctzen TH, Thomsen RW, et al. Infections in temporal proximity to HPV vaccination and adverse effects following vaccination in Denmark: a nationwide register-based cohort study and case-crossover analysis. PLoS Med. 2021;18(9):e1003768. https:\/\/doi.org\/10.1371\/journal.pmed.1003768.","journal-title":"PLoS Med"},{"issue":"4","key":"1204_CR11","first-page":"A5064","volume":"62","author":"L Brinth","year":"2015","unstructured":"Brinth L, Theibel AC, Pors K, Mehlsen J. Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J. 2015;62(4):A5064.","journal-title":"Dan Med J"},{"issue":"1","key":"1204_CR12","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1186\/s12889-018-6268-x","volume":"18","author":"CH Suppli","year":"2018","unstructured":"Suppli CH, Hansen ND, Rasmussen M, Valentiner-Branth P, Krause TG, M\u00f8lbak K. Decline in HPV-vaccination uptake in Denmark\u2013 the association between HPV-related media coverage and HPV-vaccination. BMC Public Health. 2018;18(1):1360. https:\/\/doi.org\/10.1186\/s12889-018-6268-x.","journal-title":"BMC Public Health"},{"key":"1204_CR13","unstructured":"Danish Medicines Agency. Meld en bivirkning ved en COVID-19 vaccine - for borgere. 2021. https:\/\/laegemiddelstyrelsen.dk\/da\/bivirkninger\/bivirkninger-ved-medicin\/meld-en-bivirkning\/mennesker\/meld-en-bivirkning-ved-en-covid-19-vaccine-for-borgere-\/. Accessed 8 Feb 2024."},{"key":"1204_CR14","doi-asserted-by":"publisher","first-page":"n1114","DOI":"10.1136\/bmj.n1114","volume":"373","author":"A Potteg\u00e5rd","year":"2021","unstructured":"Potteg\u00e5rd A, Lund LC, Karlstad \u00d8, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ. 2021;373:n1114. https:\/\/doi.org\/10.1136\/bmj.n1114.","journal-title":"BMJ"},{"issue":"6","key":"1204_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jpsychores.2015.03.006","volume":"78","author":"A Budtz-Lilly","year":"2015","unstructured":"Budtz-Lilly A, Fink P, \u00d8rnb\u00f8l E, Vestergaard M, Moth G, Christensen KS, et al. A new questionnaire to identify bodily distress in primary care: the \u2018BDS checklist\u2019. J Psychosom Res. 2015;78(6):536\u201345. https:\/\/doi.org\/10.1016\/j.jpsychores.2015.03.006.","journal-title":"J Psychosom Res"},{"issue":"3","key":"1204_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1600-0447.2004.00399.x","volume":"110","author":"LR Olsen","year":"2004","unstructured":"Olsen LR, Mortensen EL, Bech P. The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr Scand. 2004;110(3):225\u20139. https:\/\/doi.org\/10.1111\/j.1600-0447.2004.00399.x.","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"1204_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385\u201396.","journal-title":"J Health Soc Behav"},{"issue":"5","key":"1204_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.5271\/sjweh.3510","volume":"41","author":"A Eskildsen","year":"2015","unstructured":"Eskildsen A, Dalgaard VL, Nielsen KJ, Andersen JH, Zachariae R, Olsen LR, et al. Cross-cultural adaptation and validation of the Danish consensus version of the 10-item perceived stress scale. Scand J Work Environ Health. 2015;41(5):486\u201390. https:\/\/doi.org\/10.5271\/sjweh.3510.","journal-title":"Scand J Work Environ Health"},{"key":"1204_CR19","doi-asserted-by":"publisher","first-page":"109839","DOI":"10.1177\/1073191116645908","volume":"127","author":"TA Fergus","year":"2019","unstructured":"Fergus TA, Kelley LP, Griggs JO. Examining the Whiteley Index-6 as a screener for DSM-5 presentations of severe health anxiety in primary care. J Psychosom Res. 2019;127:109839. https:\/\/doi.org\/10.1177\/1073191116645908.","journal-title":"J Psychosom Res"},{"issue":"33","key":"1204_CR20","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1016\/j.vaccine.2023.06.069","volume":"41","author":"K Torp Hansen","year":"2023","unstructured":"Torp Hansen K, Kusk Povlsen F, Hammer Bech B, Nygaard Hansen S, Ulrikka Rask C, Fink P, et al. Immediate adverse reactions following COVID-19 vaccination among 16-65-year-old Danish citizens. Vaccine. 2023;41(33):4879\u201387. https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.069.","journal-title":"Vaccine"},{"key":"1204_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.puhe.2024.10.007","volume":"237","author":"KT Hansen","year":"2024","unstructured":"Hansen KT, Povlsen FK, Bech BH, Hansen SN, Rask CU, Fink P, et al. Does health anxiety and vaccine concern predict self-reported adverse events following COVID-19 vaccination? - a Danish national cohort study. Public Health. 2024;237:299\u2013306. https:\/\/doi.org\/10.1016\/j.puhe.2024.10.007.","journal-title":"Public Health"},{"key":"1204_CR22","doi-asserted-by":"publisher","first-page":"123136","DOI":"10.1016\/j.jns.2024.123136","volume":"463","author":"CM Nielsen","year":"2024","unstructured":"Nielsen CM, Bech BH, Hansen SN, Jensen CB, Hansen KT, Nielsen H, et al. COVID-19 vaccination and involuntary movements: a longitudinal panel study. J Neurol Sci. 2024;463:123136. https:\/\/doi.org\/10.1016\/j.jns.2024.123136.","journal-title":"J Neurol Sci"},{"issue":"9","key":"1204_CR23","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/humrep\/dead144","volume":"38","author":"C Bisgaard Jensen","year":"2023","unstructured":"Bisgaard Jensen C, Bech BH, Hansen SN, Rask CU, Fink P, Nielsen H, et al. Prevalence of and risk factors for self-reported menstrual changes following COVID-19 vaccination: a Danish cohort study. Hum Reprod. 2023;38(9):1825\u201334. https:\/\/doi.org\/10.1093\/humrep\/dead144.","journal-title":"Hum Reprod"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-025-01204-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-025-01204-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-025-01204-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T09:05:43Z","timestamp":1745399143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-025-01204-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1007\/s10654-025-01204-1","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The BiCoVac cohort was approved by the Danish Data Protection Agency under the Aarhus University comment agreement (Aarhus University j.number 2016-051-000001, sequential number 2272, date: 25 March 2021). According to Danish law, ethical approval of survey studies is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}